Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

NCT02193971 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3429

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DEVICE: BS-DES (Biostable polymer drug-eluting stent)
DEVICE: BD-DES (Biodegradable polymer drug-eluting stent)
DRUG: Prasugrel 5mg

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]